```html

Nyelosis (Syphilitic Meningitis) – A Comprehensive Medical Guide

Overview

Nyelosis, more commonly known as syphilitic meningitis, is an inflammatory condition of the meninges (the protective membranes covering the brain and spinal cord) that occurs during the late stages of untreated syphilis. The disease is caused by the spirochete bacterium Treponema pallidum. While the majority of syphilis cases are diagnosed and treated in the primary or secondary stages, an estimated < 5 % of untreated infections progress to neurosyphilis, and nyelosis represents one of its most severe forms.

• Who it affects: Adults of any age, but the condition is most common in men who have sex with men (MSM) and in people living with HIV, because co‑infection accelerates progression to neurosyphilis.
• Prevalence: In the United States, neurosyphilis was reported in 1.5 per 100,000 people in 2022, with men accounting for ~75 % of cases (CDC, 2023). Global data are limited, but WHO estimates that > 12 million people have active syphilis infections worldwide, and a fraction of these develop neurosyphilis.

Symptoms

Symptoms of nyelosis reflect meningeal irritation and central‑nervous‑system (CNS) dysfunction. They may develop gradually over weeks to months.

• Headache: Persistent, often worsening in the morning or when lying flat.
• Neck stiffness (nuchal rigidity): Difficulty flexing the neck forward.
• Photophobia: Sensitivity to light.
• Fever: Low‑grade to high‑grade, may be intermittent.
• Altered mental status: Confusion, disorientation, or decreased concentration.
• Seizures: Focal or generalized convulsions.
• Auditory or visual disturbances: Tinnitus, hearing loss, blurred vision, or cranial nerve palsies.
• Memory loss & personality changes: Often mistaken for psychiatric illness.
• Gait instability: Ataxia or difficulty walking.
• Paretic weakness: Weakness in the limbs, sometimes mimicking stroke.
• Onset of “general paresis”: Progressive dementia and motor decline that can follow chronic meningitis.
• Skin manifestations: While not a direct meningitis symptom, concomitant syphilitic lesions (e.g., gummas, condyloma lata) often coexist and may clue clinicians to the underlying infection.

Causes and Risk Factors

Nyelosis is caused by the hematogenous spread of Treponema pallidum into the central nervous system. Several factors increase the likelihood of this progression:

• Untreated or inadequately treated syphilis: Especially late latent syphilis lasting > 1‑2 years.
• HIV co‑infection: HIV impairs immune surveillance, accelerating CNS invasion (CDC, 2023).
• Immunosuppression: Organ transplant recipients, patients on chronic steroids or biologics.
• Male gender & MSM behavior: Higher rates of syphilis acquisition.
• Alcohol or drug misuse: May hinder healthcare access and adherence to treatment.
• Older age: Immune function wanes with age, increasing the risk of late complications.

Diagnosis

Diagnosing nyelosis requires a combination of clinical suspicion, cerebrospinal fluid (CSF) analysis, and serologic testing.

1. Clinical Evaluation

Physicians assess symptom patterns, risk factors, and any prior documented syphilis. A detailed sexual history and review of past treatments are essential.

2. Serologic Tests for Syphilis

• Non‑treponemal tests: Rapid plasma reagin (RPR) or Venereal Disease Research Laboratory (VDRL) – quantitative results help gauge disease activity.
• Treponemal tests: Fluorescent treponemal antibody‑absorbed (FTA‑ABS) or Treponema pallidum particle agglutination assay (TP‑PA) – confirmatory.

3. Cerebrospinal Fluid (CSF) Examination

Performed via lumbar puncture. Typical CSF findings in nyelosis include:

• Elevated white blood cell count (pleocytosis) – usually < 25 cells/µL, predominantly lymphocytes.
• Increased protein concentration (> 45 mg/dL).
• Decreased glucose (optional, may be normal).
• Positive CSF VDRL – the gold‑standard test for neurosyphilis, though sensitivity is only ~70 %.

4. Neuroimaging

MRI with contrast is preferred; it can reveal meningeal enhancement, hydrocephalus, or cerebral infarcts secondary to vasculitis. CT is used when MRI is unavailable.

5. Additional Tests

• Electroencephalogram (EEG) – useful if seizures are present.
• Neuropsychological testing – to quantify cognitive deficits.

Treatment Options

Prompt antimicrobial therapy is the cornerstone of treatment. Adjunctive measures address symptoms and prevent complications.

1. Antibiotic Therapy

• Penicillin G (IV): Aqueous crystalline penicillin 18‑24 million units per day, administered as 3‑4 million units every 4 hours for 10‑14 days (CDC, 2021). This regimen achieves therapeutic CSF concentrations.
• Alternative for penicillin‑allergic patients:
  • Desensitization to penicillin followed by the standard regimen (preferred).
  • If desensitization is not possible, ceftriaxone 2 g IV daily for 10‑14 days may be used, though evidence is less robust.

2. Management of Acute Symptoms

• Analgesics & antipyretics: Acetaminophen or ibuprofen for headache/fever.
• Anticonvulsants: Levetiracetam or valproic acid for seizure control.
• Corticosteroids: Short courses may reduce severe meningeal inflammation, but are not routinely recommended.

3. Follow‑up & Monitoring

CSF should be re‑examined at 6 months and then yearly until normalization of VDRL and cell count. Serologic titers (RPR) are also tracked; a fourfold decline at 6‑12 months indicates adequate response.

4. Lifestyle and Supportive Care

• Complete the full antibiotic course even if symptoms improve.
• Maintain hydration and adequate rest.
• Engage in physical therapy for gait or coordination problems.
• Seek counseling or support groups, especially if dealing with stigma.

Living with Nyelosis (Syphilitic Meningitis)

Survivors often continue to experience residual neurological deficits. The following strategies can improve quality of life:

• Medication adherence: Set alarms or use pill‑organizers.
• Cognitive rehabilitation: Work with a neuropsychologist on memory‑training exercises.
• Physical therapy: Balance and strength training to reduce fall risk.
• Hearing & vision care: Annual audiology and ophthalmology exams if deficits were present.
• Sexual health: Inform partners, use condoms, and get regular STI screenings.
• Psychological support: Anxiety, depression, or post‑traumatic stress are common; therapy and, if needed, medication can be beneficial.
• Vaccinations: Stay up‑to‑date on flu, pneumococcal, and COVID‑19 vaccines, especially if immunocompromised.

Prevention

Because nyelosis is a late manifestation of syphilis, prevention targets the primary infection.

• Safe sexual practices: Consistent condom use, limiting number of partners, and regular STI testing (at least annually for sexually active individuals at risk).
• Prompt treatment of syphilis: A single dose of intramuscular benzathine penicillin G (2.4 MU) cures early syphilis and prevents progression.
• Partner notification & treatment: “Contact tracing” reduces reinfection.
• HIV testing & treatment: Controlling HIV lowers neurosyphilis risk.
• Education: Public health campaigns aimed at MSM communities and high‑risk groups.

Complications

If left untreated, nyelosis can lead to serious, sometimes irreversible outcomes:

• General paresis: Progressive dementia, psychiatric symptoms, and motor weakness.
• Tabes dorsalis: Degeneration of dorsal spinal columns causing severe sensory loss, lightning‑like pains, and ataxia.
• Stroke: Syphilitic vasculitis can produce cerebral infarctions.
• Hydrocephalus: Obstructive CSF flow due to meningeal fibrosis.
• Seizure disorder: Chronic epilepsy may develop.
• Mortality: Severe meningitis can be fatal, especially in immunocompromised patients.

When to Seek Emergency Care

---

References:

1. Centers for Disease Control and Prevention. Syphilis – CDC. Updated 2023.
2. National Institutes of Health. Neurosyphilis: A Review of Clinical Manifestations, Diagnosis, and Management. J Clin Med. 2020.
3. Mayo Clinic. Syphilis. Accessed June 2026.
4. World Health Organization. Syphilis Fact Sheet. 2022.
5. Cleveland Clinic. Syphilis Overview. 2024.
6. U.S. Public Health Service. Sexually Transmitted Infections Treatment Guidelines, 2021.

```